Northwestern Mutual Wealth Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.19M | Buy |
38,761
+6,627
| +21% | +$386K | ﹤0.01% | 1073 |
|
|
2025
Q4 | $1.91M | Buy |
32,134
+5,513
| +21% | +$300K | ﹤0.01% | 1069 |
|
|
2025
Q3 | $1.44M | Sell |
26,621
-400
| -1% | -$22.9K | ﹤0.01% | 1110 |
|
|
2025
Q2 | $1.49M | Buy |
27,021
+13,803
| +104% | +$813K | ﹤0.01% | 1039 |
|
|
2025
Q1 | $934K | Buy |
13,218
+232
| +2% | +$15.6K | ﹤0.01% | 1125 |
|
|
2024
Q4 | $854K | Sell |
12,986
-1,541
| -11% | -$103K | ﹤0.01% | 1121 |
|
|
2024
Q3 | $1.02M | Sell |
14,527
-380,333
| -96% | -$31.8M | ﹤0.01% | 1059 |
|
|
2024
Q2 | $32.5M | Sell |
394,860
-167,516
| -30% | -$13.9M | 0.03% | 256 |
|
|
2024
Q1 | $49.1M | Buy |
562,376
+42,063
| +8% | +$3.77M | 0.05% | 183 |
|
|
2023
Q4 | $50.2M | Buy |
520,313
+51,550
| +11% | +$4.56M | 0.06% | 170 |
|
|
2023
Q3 | $41.5M | Buy |
468,763
+34,120
| +8% | +$3.04M | 0.05% | 174 |
|
|
2023
Q2 | $37.7M | Buy |
434,643
+43,887
| +11% | +$4.13M | 0.05% | 188 |
|
|
2023
Q1 | $38M | Buy |
390,756
+239,135
| +158% | +$24.8M | 0.05% | 176 |
|
|
2022
Q4 | $15.7M | Buy |
151,621
+13,891
| +10% | +$1.3M | 0.02% | 273 |
|
|
2022
Q3 | $11.7M | Buy |
137,730
+67,179
| +95% | +$5.98M | 0.02% | 277 |
|
|
2022
Q2 | $5.85M | Buy |
70,551
+1,598
| +2% | +$127K | 0.01% | 383 |
|
|
2022
Q1 | $5.32M | Buy |
68,953
+58,594
| +566% | +$4.9M | 0.01% | 419 |
|
|
2021
Q4 | $915K | Sell |
10,359
-916
| -8% | -$75.6K | ﹤0.01% | 856 |
|
|
2021
Q3 | $872K | Buy |
11,275
+2,313
| +26% | +$182K | ﹤0.01% | 802 |
|
|
2021
Q2 | $748K | Sell |
8,962
-96
| -1% | -$7.61K | ﹤0.01% | 847 |
|
|
2021
Q1 | $684K | Buy |
9,058
+209
| +2% | +$17.1K | ﹤0.01% | 822 |
|
|
2020
Q4 | $775K | Buy |
8,849
+3,710
| +72% | +$294K | ﹤0.01% | 711 |
|
|
2020
Q3 | $391K | Buy |
5,139
+2,331
| +83% | +$236K | ﹤0.01% | 819 |
|
|
2020
Q2 | $346K | Buy |
2,808
+1,164
| +71% | +$116K | ﹤0.01% | 797 |
|
|
2020
Q1 | $139K | Buy |
1,644
+121
| +8% | +$10.4K | ﹤0.01% | 1000 |
|
|
2019
Q4 | $129K | Buy |
1,523
+482
| +46% | +$36.4K | ﹤0.01% | 1119 |
|
|
2019
Q3 | $70K | Sell |
1,041
-71
| -6% | -$5.47K | ﹤0.01% | 1295 |
|
|
2019
Q2 | $95K | Sell |
1,112
-3
| -0.3% | -$257 | ﹤0.01% | 1142 |
|
|
2019
Q1 | $98K | Buy |
1,115
+289
| +35% | +$26.8K | ﹤0.01% | 1110 |
|
|
2018
Q4 | $70K | Sell |
826
-188
| -19% | -$17.9K | ﹤0.01% | 1119 |
|
|
2018
Q3 | $98K | Sell |
1,014
-37
| -4% | -$3.69K | ﹤0.01% | 1045 |
|
|
2018
Q2 | $99K | Buy |
1,051
+408
| +63% | +$35.7K | ﹤0.01% | 1002 |
|
|
2018
Q1 | $52K | Buy |
643
+6
| +0.9% | +$515 | ﹤0.01% | 1178 |
|
|
2017
Q4 | $57K | Buy |
637
+84
| +15% | +$7.3K | ﹤0.01% | 1105 |
|
|
2017
Q3 | $52K | Sell |
553
-105
| -16% | -$9.28K | ﹤0.01% | 1097 |
|
|
2017
Q2 | $59K | Sell |
658
-38
| -5% | -$3.46K | ﹤0.01% | 1030 |
|
|
2017
Q1 | $61K | Sell |
696
-1,306
| -65% | -$116K | ﹤0.01% | 972 |
|
|
2016
Q4 | $165K | Buy |
+2,002
| New | +$172K | ﹤0.01% | 687 |
|
|
2016
Q3 | – | Sell |
-2,457
| Closed | -$191K | – | 339 |
|
|
2016
Q2 | $191K | Buy |
2,457
+1,281
| +109% | +$109K | ﹤0.01% | 597 |
|
|
2016
Q1 | $97K | Sell |
1,176
-259
| -18% | -$21.1K | ﹤0.01% | 706 |
|
|
2015
Q4 | $150K | Sell |
1,435
-267
| -16% | -$27.9K | ﹤0.01% | 562 |
|
|
2015
Q3 | $179K | Sell |
1,702
-364
| -18% | -$48.6K | ﹤0.01% | 496 |
|
|
2015
Q2 | $283K | Buy |
2,066
+72
| +4% | +$8.92K | 0.01% | 419 |
|
|
2015
Q1 | $248K | Buy |
1,994
+755
| +61% | +$80K | 0.01% | 413 |
|
|
2014
Q4 | $112K | Sell |
1,239
-50
| -4% | -$4.16K | ﹤0.01% | 501 |
|
|
2014
Q3 | $93K | Hold |
1,289
| – | – | ﹤0.01% | 508 |
|
|
2014
Q2 | $80K | Sell |
1,289
-217
| -14% | -$13.1K | ﹤0.01% | 519 |
|
|
2014
Q1 | $102K | Buy |
1,506
+1,132
| +303% | +$83.4K | ﹤0.01% | 487 |
|
|
2013
Q4 | $26K | Buy |
374
+303
| +427% | +$20.6K | ﹤0.01% | 732 |
|
|
2013
Q3 | $5K | Buy |
71
+39
| +122% | +$2.59K | ﹤0.01% | 1006 |
|
|
2013
Q2 | $2K | Buy |
+32
| New | +$1.99K | ﹤0.01% | 1077 |
|
Other funds holding BMRN
VCM
VPM
